Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 3Pharmathen SA
02 3Towa Pharmaceutical
03 2Mankind Pharma
04 3A. Menarini
05 2ANI Pharmaceuticals Inc
06 2ARTHUR GRP
07 2Accord healthcare
08 2Actavis Inc
09 6Adamed Pharma
10 2Ajanta Pharma Limited
11 2Alkem Laboratories
12 3Alter Laboratories Sa
13 2Amneal Pharmaceuticals
14 4Ascent Innovative Medicines
15 2Aurobindo Pharma Limited
16 2Cadila Pharmaceuticals
17 2Chartwell Pharmaceuticals llc
18 3Cinfa
19 2Cipla
20 3DOC Generici
21 3EG Spa
22 2Glenmark Pharmaceuticals
23 3Grindeks AS
24 2Hetero Drugs
25 1Ind Swift Laboratories Limited
26 4Intas Pharmaceuticals
27 3Intas Third Party Sales 2005 Sl
28 2Jubilant Generics
29 2KYE Pharmaceuticals
30 6Krka
31 3LABORATORIOS NORMON SA
32 2MENARINI INTL
33 23Menarini
34 3Menarini South Africa (Pty) Ltd
35 2Micro Labs Limited
36 2Novast Laboratories
37 1Pantson Pharma Pvt. Limited
38 2Piramal Pharma Solutions
39 1Ravenbhel Pharma
40 2Rising Pharmaceuticals Inc
41 3STADA Arzneimittel
42 2ScieGen Pharmaceuticals
43 2Spil
44 2Sun Pharmaceutical Industries Limited
45 2Sunshine Lake Pharma
46 5Teva Pharmaceutical Industries
47 2Torrent Pharmaceuticals Limited
48 3Umedica Laboratories
49 5Unichem Laboratories Limited
50 2Unichem Pharmaceuticals USA, Inc
51 2VKT Pharma
52 1Vega Biotech Pvt. Ltd.
53 2i3 Pharmaceuticals
01 5ER Tablet
02 1EXTENDED RELEASETABLET
03 3Extended Release Tablet
04 12Extended Release Tablets
05 44Extended-Release Tablet
06 2GRANULES, EXTENDED RELEASE;ORAL
07 3Modified Release Tablet
08 3Prolonged Release Tablet
09 3Prolonged-Release Tablet
10 1Ranolazina 375Mg 60 Units Oral Use Rp
11 1Ranolazina 500Mg 60 Units Oral Use Rp
12 1Ranolazina 750Mg 60 Units Oral Use Rp
13 3SRT
14 1TABLET
15 2TABLET (EXTENDED-RELEASE)
16 56TABLET, EXTENDED RELEASE;ORAL
17 9Tablet
18 4XR Tablet
01 3Allowed
02 3Approved
03 41Authorized
04 18DISCN
05 7Generic
06 3Originator
07 2Prescription
08 38RX
09 3Suspensed
10 36Blank
01 2ASPRUZYO SPRINKLE
02 2CORZYNA
03 1Nefazor
04 5RANEXA
05 3RANOLAZINA DOC GENERIC
06 3RANOLAZINA EG
07 3RANOLAZINA KRKA
08 54RANOLAZINE
09 3RANOZEK
10 1Ranazine 500 SR
11 23Ranexa
12 1Ranexa 375 mg
13 1Ranexa 500 mg
14 1Ranexa 750 mg
15 3Ranolazina Alter
16 3Ranolazina Cinfa
17 3Ranolazina Intas
18 3Ranolazina Krka
19 3Ranolazina Normon
20 3Ranolazina Stada
21 3Ranolazina Umedica
22 3Ranolazine Teva
23 3Ranolazine Thinks
24 3Ranozek
25 21Blank
01 2Canada
02 3Greece
03 17India
04 18Italy
05 3Latvia
06 3South Africa
07 44Spain
08 3Sweden
09 3Switzerland
10 58USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 375MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ranolazine Thinks
Dosage Form : Extended-Release Tablet
Dosage Strength : 500MG
Packaging :
Approval Date : 2024-02-06
Application Number : 89168
Regulatory Info : Authorized
Registration Country : Spain
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2020-02-12
Application Number : 212284
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 750MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ranolazine Thinks
Dosage Form : Extended-Release Tablet
Dosage Strength : 375MG
Packaging :
Approval Date : 2024-02-06
Application Number : 89167
Regulatory Info : Authorized
Registration Country : Spain
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ranolazine Thinks
Dosage Form : Extended-Release Tablet
Dosage Strength : 750MG
Packaging :
Approval Date : 2024-02-06
Application Number : 89169
Regulatory Info : Authorized
Registration Country : Spain
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2020-02-12
Application Number : 212284
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2019-05-28
Application Number : 208862
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2019-05-28
Application Number : 208862
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2021-03-11
Application Number : 207690
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2021-03-11
Application Number : 207690
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2022-12-23
Application Number : 209081
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2022-12-23
Application Number : 209081
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2013-07-29
Application Number : 201046
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2013-07-29
Application Number : 201046
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number : 208174
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1000MG
Packaging :
Approval Date :
Application Number : 208174
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANEXA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2007-02-12
Application Number : 21526
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANEXA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2006-01-27
Application Number : 21526
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
